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Abstract
Background: Long-chain polyunsaturated fatty acids (PUFAs) are major components of the phospholipids that forming
the cell membrane. Insufficient availability of PUFAs during prenatal period decreases accretion of docosahexaenoic acid
(DHA) in the developing brain. DHA deficiency is associated with impaired attention and cognition, and would precipitate
psychiatric symptoms. However, clinical studies on the potential benefits of dietary DHA supplementation to neural
development have yielded conflicting results.
Methods: To further investigate the neurochemical influence of maternal PUFAs levels, we assessed the functioning of
various neurotransmitter systems including glutamatergic, dopaminergic, norepinephrinergic and serotoninergic systems
in the brain of neonatal female rats by HPLC-MS/MS. Meanwhile, the cell proliferation of neonatal rats was investigated
using immunefluorescence.
Results: Different maternal n-3 PUFAs dietary influenced the FA composition, cell proliferation in the dentate gyrus of
hippocampus and the contents of γ-aminobutyric acid (GABA), glutamine (GLN), dopamine (DA) and its metabolites
[3,4- dihydroxyphenyl acetic acid (DOPAC) and homovanillic acid (HVA)], norepinephrine (NE), vanilmandelic acid
(VMA) and 5-HT turnover in the brain of neonatal rats. However, the mRNA expression of key synthase of
neurotransmitters remains stable.
Conclusions: Our study showed that maternal deficiency of n-3 PUFAs might play an important role in central
nervous system of neonatal female rats mainly through impairing the normal neurogenesis and influencing
glutamatergic system and 5-HT turnover.
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Background
Polyunsaturated fatty acids (PUFAs) are major compo-
nents of the phospholipids that form the cell membranes
of tissues and thus play an important role in the struc-
ture of neuronal cells in the central nervous system,
where they are of the highest concentrations [1]. The
lipid requirements of young infants, particularly the
requirements for the n–6 and n–3 fatty acids for brain
growth and development, are currently an area of intense
interest. As indicated in previous studies, accumulation of
large amounts of arachidonic acid (20:4n–6, AA) and
docosahexaenoic acid (22:6n–3, DHA) in the membranes
of the brain during late prenatal and early postnatal is
essential for its development [2]. To the contrary, vari-
ation in brain FA composition, decreased DHA in specific,
affects neurodevelopment, alters visual, attention and
cognitive functions, and exhibited symptoms of anxiety,
aggression and depression in animals models [3]. Previous
findings demonstrated that the link between n-3 fatty acid
deficiency and vulnerability to depressive symptoms is
more robust in females [4], which suggested that gender
differences might be involved in the pathophysiology of
n-3 fatty acid deficiency induced neurodevelopment
impairment. Therefore, one of our aims in the present
study is to determine the effects of maternal n-3 PUFAs
deficiency or supplementation on brain FA composition
in neonatal female rats.
The mechanisms underlying n-3 PUFAs deficiency
induced neurodevelopment impairment are still unclear.
One of possible mechanisms may be related to its effects
on multiple neurotransmitter systems. N-3 PUFAs has
been shown to regulate many of the neurobiological
systems, such as glutamatergic system, dopaminergic
system, noradrenergic system and serotonergic system
[5], and related receptors. Animal studies suggested that
reduced brain DHA could induce degradation of gluta-
matergic transmission in hippocampus of aging rats
[6]. As an important part of glutamine(GLN)/glutama-
te(GLU) (gamma-aminobutyric acid, GABA) cycle (GGC),
dishomeostasis of GLN might contribute to the changes in
GLUergic or GABAergic system [7]. Additionally, inad-
equate n-3 PUFAs diet was reported to alter densities of
dopamine receptors, including D1 and D2 [8]. Moreover,
n-3 PUFAs diet may also have an effect on 5-HT turnover
[9]. To further understand how the development of central
nervous systems are affected by the availability of dietary
n-3 PUFA, the other aim of the current study is to deter-
mine the expression of the key enzymes involved in the
neurotransmitter metabolism and the levels of different
neurotransmitters and their metabolites in the brain of
rats. Then, we used Pearson correlation analysis to evaluate
possible associations between certain FA and neurotrans-
mitters. Cell proliferation in dentate gyrus of hippocampus
was also investigated in the present study.
Results
Maternal deficiency of PUFAs decrease the cell
proliferation in neonatal female rats
Newborn cells in the developing rat dentate gyrus can
be quantified by immunostaining of BrdU incorporated
into the nuclei of dividing cells [10]. The effect of intra-
peritoneal injection on dentate gyrus neurogenesis was
evaluated by comparing the average number of BrdU-
positive cells per area in control. ANOVA analyses showed
that cell proliferation in neonatal female rats was signifi-
cant decreased in Deficient group than that in Control
group (P < 0.01, Fig. 1).
Fatty acid composition in liver
Treatment of maternal rats with the deficient diet de-
creased the percentage of C18:0 (stearic acid), C18:1n9c
(oleic acid), C22:6n3 (DHA), total n-3 PUFA and the
ratio of n-3/n-6 and DHA/AA, and increased the per-
centage of C16:0 (palmitic acid), C18:2n6c (methyl lino-
leate), C20:4n6 (AA), C24:0 (tetracosanoic acid) and
total n-6 PUFA in the livers of neonatal female rats
compared with control group. High (n-3) content in the
maternal diet resulted in decreased levels of C16:0,
C18:1n9c, C18:2n6c, AA and total n-6 PUFA, and in-
creased levels of C18:3n3, C20:5n3, C22:5n3 (EPA),
DHA and total n-3 PUFA compared with Control off-
spring. The ratio of n-3/n-6 rose about eightfold and the
ratio of DHA/AA increased sixfold in the Supplementary
group compared to Control (Shown in Table 1).
Fatty acid composition in brain
Maternal deficient n-3 diet decreased the percentages of
C18:1n9c, DHA, total n-3 PUFAs, and the ratio of n-6/
n-3 as well as DHA/AA, and increased the percentage of
C18:0, total n-6 PUFAs in the brain of neonatal female
rats compared with control group. High (n-3) content in
the maternal diet resulted in decreased levels of AA,
total n-6 PUFAs and increased levels of C18:1n9c, DHA
and total n-3 PUFAs compared with Control offspring
(Shown in Table 2). Interestingly, the ratio of n-3/n-6
and DHA/AA only increased two times in the Supple-
mentary group compared to the Control group, which is
far less than the proportion in liver.
Brain neurochemistry and gene expression of related
enzyme
Maternal n-3 PUFAs deficiency resulted in significant
increase of γ-aminobutyric acid (GABA) status (Table 3,
p < 0.01) and decrease of glutamine (Gln, Table 3, p < 0.01)
in the brain of neonatal offspring. Correspondingly, mater-
nal n-3 PUFAs supplementation increased the Gln level in
the brain of neonatal rats whereas the level of GABA
remains unchanged. However both maternal deficient and
supplementary in n-3 PUFAs did not alter the level of
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glutamic acid (Glu) and the expression of glutamate de-
carboxylase (GAD) 67, GAD65 and glutamine synthetase
(GS) (Fig. 2a-c), which are crucial for the biosynthesis of
GABA. GABA is produced in the CNS via decarboxylation
of GLU, in a reaction catalyzed by glutamic acid decarb-
oxylase (GAD). Within the CNS, the majority of GLU is
produced from glutamine (GLN) via the enzyme glutamin-
ase. Regarding the dopamine system, maternal deficient
diets did not alter the level of DA (Table 3.) and the
expression of the key DA synthase emzyme tyrosine
hydroxylase (TH, Fig. 2e) in the brain of neonatal female
rats, however the DA metabolites [3,4- dihydroxyphenyl
acetic acid (DOPAC) and homovanillic acid (HVA)] in-
creased significantly (Table 3. p < 0.01). Female rats whose
mother maintained on n-3 PUFAs Supplementary diet
exhibited significant deficits in DA levels and surplus in
DOPAC relative to Control group, but the mRNA levels of
TH remain stable. Supplementary group also exhibited
decreased norepinephrine (NE), without altering the me-
tabolites vanilmandelic acid (VMA) and 4-Hydroxy-3-
methoxyphenylglycol (MHPG). Both maternal deficient or
supplementary diet had no effect on tryptophan (TRP) and
serotonin (5-HT) levels and did not affect the expression
of tryptophan hydroxylase 2 (TPH2) (Fig. 2d). But Supple-
mentary group exhibited increased kynurenic acid (KYN)
compared with Control. Intriguingly, the metabolite of
5-HT, 5-hydroxy indole acetic acid (5-HIAA), and the
ratio of 5-HIAA to 5-HT, were generally enhanced in
supplementary group, and decreased in deficient group.
The correlation of FA composition and neurotransmitter
concentration in brain of neonatal rat
A significant interaction of brain AA, DHA status, DHA/
AA ratio and neurotransmitter concentrations was de-
tected. Pearson correlation analysis revealed that the brain
level of AA was negatively correlated with the content of
GLN (Fig. 3a, r = 0. 4265, P < 0.01), 5-HIAA (Fig. 3b, r = 0.
6061, P < 0.01) and the ratio of 5-HIAA/5-HT (Fig. 3c,
r = 0. 6128, P < 0.01). The brain level of DHA was posi-
tively correlated with the content of GLN (Fig. 3d, r = 0.
7352, P < 0.01), 5-HIAA (Fig. 3e, r = 5950, P < 0.01) and
the ratio of 5-HIAA/5-HT (Fig. 3f, r = 0. 6751, P < 0.01).
Similarly, the ratio of DHA/AA was also positively
correlated with the content of GLN (Fig. 3g, r = 0.7732,
P < 0.01), 5-HIAA (Fig. 3h, r = 0.7200 P < 0.01) and the
ratio of 5-HIAA/5-HT (Fig. 3i, r = 0. 8297, P < 0.01).
Fig. 1 Maternal n-3 PUFAs deficiency decreases the neurogenesis in dentate gyrus (DG) region of neonatal hippocampus. BrdU was examined at
the DG region by immunofluorescence (a); Quantification of BrdU at the DG region of neonatal hippocampus (one-way ANOVA, TUKEY post hoc
test, *p < 0.05 vs. Control) (b). n = 5 in each group
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Discussion and conclusions
Fatty acid (FA) composition affects the physicochemical
properties of the membrane, thus influences the con-
formation and function of membrane-bound proteins,
such as receptors, ion channels, and transporters [11].
LC-PUFA also serve as precursors for inter- and intra-
cellular signals such as prostaglandins and thrombox-
anes, and modulate the gene expression by activating of
transcription factors. Moreover, accumulating studies
have shown that maternal diets deficient in n-3 PUFAs
decreased the brain DHA content of offspring [12],
while the deficiency in brain DHA may represent a pre-
ventable neurodevelopmental risk factor for the subse-
quent emergence of psychopathology. In the present
study, we discovered that diverse maternal n-3 PUFAs
dietary altered the FA composition of offsprings in liver
and brain. Maternal deficient n-3 diet decreased the per-
centages of DHA, total n-3 PUFAs, and increased the
percentage of total n-6 PUFAs in the liver and brain of
neonatal female rats compared with control group. Since
brain DHA is pivotal for the neurodevelopment, and de-
ficiency on DHA may aggravate symptoms of anxiety
and depression, adequate of N-3 PUFAs during preg-
nancy is essential for the development of rats.
Neurogenesis is established during gestation in most
brain region and is completed before birth except in the
dentate gyrus (DG) of hippocampal [13]. The normal
development of DG is very important to learning and mem-
ory [14]. N-3 PUFAs was reported to have neurogenesis-
promoting properties [15]. Contrarily, maternal dietary n-3
Table 1 Effects of maternal dietary (n-3) PUFA treatment on
liver fatty acid composition of 1st-litter neonatal female rats
FA Percent of Total FA (area percent)
Deficient Control Supplementary
C14:0 1.0 ± 0.1 1.0 ± 0. 0 1.0 ± 0.2
C16:0 27.1 ± 0.5 26.3 ± 1.2 22. 3 ± 1.2*
C16:1 1.4 ± 0.1 1.6 ± 0.0 1.6 ± 0.2
C18:0 6.7 ± 0. 4* 9.5 ± 0.8 8.2 ± 0.6
C18:1n9c 11.6 ± 0.6** 18.5 ± 0.8 12.6 ± 0.7**
C18:2n6c 20.8 ± 1.3 16.6 ± 0.5 12.4 ± 0.9*
C18:3n3 0 0 0.8 ± 0. 1*
C20:4n6 16.8 ± 1.0* 13.5 ± 0.5 6.1 ± 0.4**
C20:5n3 0 0.5 ± 0. 0 4.0 ± 0.5**
C24:0 3.0 ± 0.1** 1.6 ± 0. 2 1.5 ± 0. 2
C22:5n3 0 0 3.605 ± 0. 3*
C22:6n3 0.8 ± 0. 2* 4.0 ± 0.5 11.1 ± 1.1**
Other MUFA 1.7 ± 0. 1** 2.6 ± 0. 1 1.9 ± 0. 1**
Other n-6 PUFA 3.7 ± 0. 4* 1.0 ± 0. 1 0
Total n-3 PUFA 0.7 ± 0. 2** 3.9 ± 0.5 21.0 ± 0.2**
Total n-6 PUFA 40.7 ± 1.6** 30.7 ± 0. 4 18.8 ± 1.4**
n-3 PUFA/n-6 PUFA 1.7 ± 0.6** 12.7 ± 1.6 107.3 ± 7**
DHA/AA 0.04 ± 0.01** 0.31 ± 0.03 1.95 ± 0.08**
Liver FA Composition was expressed as mean ± SEM (n = 5-6 per group). Data
were analyzed by variance (ANOVA) for multiple comparisons followed by
TUKEY or Dunnett’s t test for post-hoc test. ** p < 0.01, * p < 0.05 vs. Control
Table 2 Effects of maternal dietary (n-3) PUFA treatment on
whole brain fatty acid composition of 1st-litter neonatal female
rats
FA Percent of Total FA (area percent)
Deficient Control Supplementary
C14:0 2.4 ± 0.1 2.1 ± 0.2 2.5 ± 0.0
C16:0 42.5 ± 1.3 39.7 ± 1.1 40.5 ± 0.5
C16:1 3.0 ± 0.0 4.448 ± 0.1 4.5 ± 0.1
C18:0 20.8 ± 0.4* 19.7 ± 0.2 20.2 ± 0.1
C18:1n9c 12.1 ± 0.1** 13.2 ± 0.1 13.7 ± 0.2*
C20:4n6 9.2 ± 0.3 9.4 ± 0.3 7.1 ± 0.5**
C22:6n3 0** 5.3 ± 0.2 7.3 ± 0.3**
Other MUFA 2.9 ± 0.0** 3.1 ± 0.0 3.2 ± 0.1
Other n-6 PUFA 6.2 ± 0.2** 1.5 ± 0.1 0
Total n-3 PUFA 0** 5.2 ± 0.2 7.3 ± 0.4**
Total n-6 PUFA 15.4 ± 0.5** 10.7 ± 0.7 7.2 ± 0.5**
n-3 PUFA/n-6 PUFA 0** 49.2 ± 1.6 105.3 ± 10.2**
DHA/AA 0** 0.56 ± 0.02 1.07 ± 0.07**
Brain FA Composition was expressed as mean ± SEM (n = 5-6 per group). Data
were analyzed by variance (ANOVA) for multiple comparisons followed by
TUKEY or Dunnett’s t test for post-hoc test. ** p < 0.01, * p < 0.05 vs. Control
Table 3 The content of major neurotransmitters and their
metabolites in whole brain of 1st-litter neonatal female rats
Compound Deficient Control Supplementary
GABA (ug/g) 273.2 ± 7.29** 225.0 ± 7.9 220.7 ± 14.1
GLU (ug/g) 604.8 ± 33.1 580.5 ± 56.2 550.7 ± 50.6
GLN (ug/g) 264.7 ± 18.1** 422.1 ± 32.4 788.5 ± 53.2**
DA (ng/g) 98.2 ± 10.8 106.4 ± 18.5 49.8 ± 4.5**
DOPAC (ng/g) 4848.6 ± 286.9** 3797.4 ± 178.8 4407.3 ± 221.5*
HVA (ng/g) 11092.5 ± 963.5** 7839.8 ± 908.1 9236.3 ± 988.0
NE (ng/g) 2026.9 ± 409.7 2240.3 ± 323.5 1046.8 ± 106.5**
MHPG (ng/g) 2844.8 ± 185.3 2583.5 ± 245.3 2870.5 ± 225.2
VMA(ng/g) 18152.5 ± 1482.2** 24125.9 ± 1439.0 26581.2 ± 1395.4
TRY (ug/g) 31.0 ± 1.9 30.8 ± 3.0 45.1 ± 3.4
5-HT (ng/g) 215.9 ± 32.3 161.8 ± 20.9 169.2 ± 14.3
5-HIAA (ng/g) 174.1 ± 19.2 223.8 ± 25.5 627.8 ± 41.7**
5-HIAA/5-HT 0.618 ± 0.1** 1.745 ± 0.3 4.226 ± 0.6**
KYN (ng/g) 507.2 ± 49.8 487.2 ± 35.6 626.0 ± 26.8**
Data were expressed as mean ± SEM (n = 6-8per group). Data were analyzed
by variance (ANOVA) for multiple comparisons followed by TUKEY or Dunnett’s
t test for post-hoc test. ** p < 0.01, * p < 0.05 vs. Control
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fatty acid deficiency can impair normal neurogenesis in
the embryonic rat brain [16]. In the present study, we
first found that maternal n-3 PUFAs deficiency signifi-
cantly decreased the number of BrdU+ cells in the
hippocampus DG in neonatal rats. This inhibition of
proliferation might reduce the neural progenitor pool
and affect subsequent neurogenesis, further leading to
the impaired learning and memory and declined in cog-
nitive abilities.
It has been postulated that the alterations of neuro-
transmission in the key brain areas play a pivotal role in
the progression of several neuropsychiatric diseases, and
the beneficial effects of n-3 PUFAs in these brain-related
disorders was, at least partially, via its modulating effect
on neurotransmission [17]. GABA is the major inhibitory
neurotransmitter in the central nervous system. GABAer-
gic neurons have been shown to control cognitive process-
ing in prefrontal and hippocampal networks [18]. Recent
study suggested that reduced brain DHA could decrease
presynaptic GLU release and uptake, further resulted in
degradation of glutamatergic transmission in hippocam-
pus of aging rats, rather than young rats [6]. GABA is
produced in the CNS via decarboxylation of GLU, in a re-
action catalyzed by glutamic acid decarboxylase (GAD).
Within the CNS, the majority of GLU is produced from
glutamine (GLN) via the enzyme glutaminase. In the
present study, maternal n-3 PUFAs deficiency significantly
decreased the brain concentration of GLN and increased
the content of GABA in offspring rats, without altering
the level of GLU and the mRNA expression of GAD. Ma-
ternal n-3 PUFAs Deficiency gave rise to the failure of the
GGC cycle (inhibition of GLN synthesis) in neonatal fe-
male rats. We speculated that the decreased GLN in
Deficient group might reflect the degradation of gluta-
matergic transmission and GABAergic transmission, and
the increase in GABA content may be the compensatory
mechanism in the organism.
The altered tissue FA composition induced by dietary
n-3 PUFAs content could affect CNS dopamine systems
[19]. Current studies between the relationship of n-3
PUFAs level and FA composition focused on the dopa-
mine receptors, which proposed that inadequate n-3
PUFAs diet could increase densities of D1 and D2 recep-
tors, but had no effect on DA content [20]. In line with
Fig. 2 Effect of maternal diet of fatty acid on mRNA levels of the metabolizing enzymes of the neurotransmitters in brain of neonatal rat. Relative
mRNA expression of GAD67 (a); Relative mRNA expression of GAD65 (b); Relative mRNA expression of GS (c); Relative mRNA expression of TPH2
(d); Relative mRNA expression of TH (e)
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previous findings, the content of DA in the neonatal fe-
male rats of n-3 PUFAs deficient group remained stable,
as well as the expression of tyrosine hydroxylase (TH),
the key synthase enzymes of DA. However, the concen-
trations of DOPAC and HVA, the primary metabolites
of DA, were concurrently elevated. It is worth noting
that maternal n-3 PUFAs supplementary significantly re-
duced the brain DA level and significantly increased the
DOPAC content in neonatal female rats. Since DA plays
a key role in governing motivation and reward process-
ing, and alterations to dopamine levels have been linked
to the onset of various psychiatric disorders including
schizophrenia, substance abuse disorders, attention-deficit/
hyperactivity disorder, and depression [21], adequate ma-
ternal n-3 PUFAs diet become essential for normal brain
development.
The role of n-3 PUFAs in modulation of noradrenergic
neurotransmission has received relatively little attention. In
animal studies, a diet containing inadequate n-3 PUFAs re-
sulted in a decreased norepinephrine (NE) in the hippo-
campus, cortex and striatum of rats [22]. However, no
alterations in regional NE reduction were found in virgin
female or postpartum female rats with brain DHA defi-
ciency [23, 24]. Similarly, the brain NE level of neonatal fe-
male rats remained stable in maternal n-3 PUFAs
deficiency group, but its metabolite VMA decreased signifi-
cantly. Unexpectedly, we first found that maternal n-3
PUFAs supplementary could reduce the content of NE
without altering the metabolites like VMA and MHPG in
neonatal female rats. We assume that the reduced NE
content in the brain may result from the reduction of
its precursor DA.
N-3 PUFAs deficiency during peri-adolescent (P21-
90) was reported to exhibit significantly greater 5-
hydroxytryptamine (5-HT) content and a significantly
smaller 5-HIAA/5-HT ratio in the prefrontal cortex
Fig. 3 The correlation of FA composition and neurotransmitter concentration in brain of neonatal rat. The correlation of the level of AA and the
content of GLN (a); The correlation of the level of AA and the content of 5-HIAA (b); The correlation of the level of AA and the ratio of 5-HIAA/5-
HT (c); The correlation of the level of DHA and the content of GLN (d); The correlation of the level of DHA and the content of 5-HIAA (e); The
correlation of the level of DHA and the ratio of 5-HIAA/5-HT (f); The correlation of the ratio of DHA/AA and the content of GLN (g); The
correlation of the ratio of DHA/AA and the content of 5-HIAA (h); The correlation of the ratio of DHA/AA and the ratio of 5-HIAA/5-HT (i)
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and hypothalamus of female adult rats [4, 9]. Further-
more, the effect of DHA efficiency on 5-HT turnover
was depended on when dietary n-3 fatty acid deficiency
was initiated, and there might be a neurodevelopmental
window in which 5-HT system was vulnerable to dys-
regulation in response to DHA deficiency. Similar to
previous results, we found that maternal n-3 PUFAs
deficiency not only slightly increased 5-HT content and
significantly reduced 5-HIAA/5-HT ratio, but also sig-
nificantly reduce 5-HIAA content in neonatal female
rats. On the contrary, maternal n-3 PUFAs supplementary
significantly increased the concentration of 5-HIAA and
the ratio of 5-HIAA/5-HT. The rate-limiting enzyme in
the biosynthesis of 5-HT in the brain is tryptophan
hydroxylase 2 (TPH2). In addition to TPH2, tryptophane
(TRY), the precursor of 5-HT, also can be metabolized by
indoleamine 2,3-dioxygenase (IDO) which is activated by
inflammatory cytokines resulting in accelerated conversion
of TRP to kynurenine (KYN) and reduced bioavailability of
TRP for 5-HT production [25], whereas n-3 PUFAs was
reported to participate in various neuro-immune regu-
lation [26, 27]. Thus, it is possible that n-3 PUFAs
levels may affect IDO activity via its immunomodulat-
ing effects. In the present study, n-3 PUFAs supplemen-
tary slightly increased TRY and significantly increased
KYN content. Whereas, the brain levels of TRY and
KYN were unchanged in n-3 PUFAs deficiency diet, in-
dicating that maternal n-3 PUFAs levels appeared to
exert no effect on KYN pathway in the brain of neo-
natal rats.
Accumulating evidence suggests that neurotransmitter
system play a vital role in neurogenesis. Antidepressant
treatment with SSRIs, which would increase the content
of 5-HT in synaptic cleft, was reported to promote cell
proliferation and neurogenesis in models of depression
[28]. Furthermore, in vivo study suggested that serotonin
plays a direct and acute regulatory role in activity-
dependent hippocampal neurogenesis [29]. Besides, the
reduction of GABA-ergic interneurons is thought to
be responsible for the aberrant neurogenesis [30]. In
the present study, both serotonin system and gluta-
matergic system of neonatal female rats were altered,
and highly associated with the content of AA, DHA
and the ratio of DHA/AA. Based on above studies, it
is easily to come to the conclusion that the inadequate
intake of N-3 PUFAs could disturb the GABA system
and 5-HT metabolites, further impairing hippocampal
neurogenesis.
In conclusion, our study showed that maternal defi-
ciency of n-3 PUFAs might have considerable effects on
central nervous system of neonatal female rats mainly
through impairing the normal neurogenesis, glutamater-
gic system and 5-HT turnover, which suggest that ad-
equate n-3 PUFA during pregenancy is essential for fetal
neurodevelopment. However, more research is needed to
evaluate the long-term effect.
Methods
Animals and husbandry
This study was approved by the Animal Care & Use
Committee of Central South University. All experiments
were performed in accordance with the Guide for Care
and Use of Laboratory Animals (Chinese Council).
Sprague-Dawley rats were initially housed in groups in
a temperature-controlled environment under a 12/12 h
light/dark cycle with ad libitum access to food and water.
Rats were randomly assigned to three groups (n = 7)
according to the content of n-3 PUFAs in their diets:
Deficient, Control and Supplementary. Breeding stock
(Female, 210-230 g; Male proven breeders; The Experi-
mental Animal Center of the Second Xiangya Hospital)
maintained on corresponding diets two weeks before mat-
ing (Female 280-300 g) until the end of the experiment.
At the time of mating, one male rat was housed with two
female rats per cage for three days. To meet all current
nutrient standards for rat pregnancy and growth [31], the
Control diet in our experiment was AIN-93G (Trophic
Animal Feed High-Tech Co., Ltd, China) formulated with
soybean oil (70 g/kg). The Deficient and Supplementary
diet were identical to the Control diet except the oil
formulation. The Deficient diet was prepared with saf-
flower oil (70 g/kg) and the Supplementary diet was pre-
pared with fish oil (20 g/kg) and soybean oil (50 g/kg).
Fatty acid composition of the diets is shown in Table 4.
The nutritional composition of diets and the fatty acid
composition of fish oil are shown in Additional file 1:
Tables S1 and S2. Chromatogram of fish oil is also pro-
vided in Additional file 2: Figure S1.
Bromodeoxyuridine treatment
To determine whether maternal n-3 FUFAs status af-
fects the cell proliferation in neonatal female rats, bro-
modeoxyuridine ((+)-5’-bromo-2’-deoxyuridine [BrdU];
Table 4 Fatty acid composition of the Experimental Diets
Fatty acid Content in diet(area percent)
Deficient Control Supplementary
C16:0 6.61 11.18 9.96
C18:0 2.31 3.17 3.39
C18:3n3 ND 4.26 3.67
C18:1n9c 11.71 24.52 22.72
C18:2n6c 79.38 55.39 47.30
C20:5n3 ND ND 7.32
C22:6n3 ND ND 4.00
Other MUFA ND 1.48 1.95
Diet fatty acid composition was determined by GC/MS using Supelco 37
Standard. ND: Not detected
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Sigma-Aldrich, USA) in 0.9 % sterile saline solution
was injected intraperitoneally at dose of 100 mg/kg.
After 2 hour, rats were sacrificed and brains were re-
moved and fixed overnight in 4 % paraformaldehyde.
After then, tissues were cryoprotecter in 30 % sucrose
in PBS before embedding. Immunefluorescence of
BrdU-labeled nuclei was measured using BrdU Assay
kit (servicebio, China) according to the protocol.
FA composition assays
A classical method for lipid extraction and purification
was applied with modification [32]. Briefly, 750 μl mixture
of dichloromethane and methanol (2:1) and 100 μM butyl-
ated hydroxytoluene (to prevent lipid peroxidation) were
added to the brain tissues, and homogenized by tissue
homogenizer. The mixture was then added with 250 μl di-
chloromethane and followed with blending for 30 s, and
250 μl water was added and blending was continued for
another 30 seconds. The lower phase was then transferred
and subsequently evaporated to dryness by nitrogen. The
residue was dissolved by n-hexane, and then 2 ml of
0.5 M KOH-MeOH was added, the sample was heated at
60 °C for 20 min. Following 10 min of cooling period,
3 ml of 12.5 % H2SO4 in methanol was added to methylate
the sample. After an additional 60 min of heating in the
water bath (60 °C), the sample vial was allowed to cool,
and 1 ml of saturated solution containing sodium chloride
and 2 ml of hexane was added. The hexane fraction was
then transferred for GC analysis. Total fatty acid compos-
ition was determined with Agilent 7890A/5975C. The col-
umn was VF-23 ms (Agilent): 30 m, (length), I.D. 0.25 mm
wide bore, film thickness of 0.25 μM. Fatty acid identifica-
tion was determined using retention times of authenticated
fatty acid methyl ester standards (Supelco 37, sigma).
Fatty acid composition data was expressed as percent-
age of peak area.
The determination of neurotransmitters
Neurotransmitters and their metabolites were quanti-
fied using high-performance liquid chromatography
coupled to tandem mass spectrometry (HPLC-MS/
MS) as previously described [33] with little modifica-
tion. Briefly, brain tissues were homogenized by tissue
homogenizer with 1 ml of 85 % ice-cold acetonitrile-
water adding 10 μl of mixed internal standard solution
(containing 20 μg/ml 3,4-dihydroxybenzylamine, 10 μg/ml
5-hydroxyindole-2-carboxylic acid and 100 μg/ml L-aspar-
tic acid-13C4,15 N). After the homogenate, the mixture
was centrifuged at 4 °C for 15 min at 10000 rpm. The
supernatant (500 μL) was then transferred and subse-
quently evaporated to dryness. For derivatization, 150 μl
of dansyl chloride solution (4 mg/ml in acetonitrile) and
50 μl of 0.1 M Na2CO3-NaHCO3 buffer (pH 11.0) were
added to the residue and reacted at 35 °C for 30 min. After
the reaction, the pH of the mixture was adjusted by
adding 10 μl of 7.5 % formic acid solution. After centrifu-
gation, the supernatant was transferred to the vial for ana-
lysis. HPLC-MS/MS analysis was carried out on a Waters
Acquity ultra-performance liquid chromatography system
(Waters, USA) with a Micromass Quattro Premier XE
tandem quadruple mass spectrometer (Waters, USA)
equipped with ESI source. The chromatographic separ-
ation was achieved on Ultimate XB-C8 column, 2.1 mm×
50 mm, 3.0 μm particle size (Welch, China). The mobile
phase for elution was a gradient established between
solvent A (water with 20 mM ammonium acetate and
0.1 % formic acid) and solvent B (acetonitrile) at a flow
rate of 0.25 ml/min. The mass spectrometer was operating
at the following parameters: capillary voltage, 3.00 kV;
extractor voltage, 3.00 V; source temperature, 120 °C; des-
olvation temperature, 450 °C; desolvation gas flow, 750 L/h;
cone gas flow, 50 L/h. Argon used as the collision gas
was introduced into the collision cell at a flow rate of
0.16 ml/min. The electrospray ionization source was
operated in the positive mode. Data acquisition was
carried out by Mass Lynx 4.1 software. Neurotransmit-
ters were quantified relative to the internal standard
areas and calibrated using standard curves.
Real-time PCR analysis
Total RNA from the brain was homogenized using Trizol
reagent (invitrogen, USA) according to the manufacturer’s
instructions. The real-time reverse transcriptase polymerase
chain reaction (RT-PCR) was used to examine the effect
of maternal n-3 PUFAs deficiency or supplementary on
certain key synthase enzymes of neurotransmitters in neo-
natal rats. Quantification of mRNAs was performed on
ABI 7900HT Detection System (Lifetech, USA) using
Table 5 Primer sequences used for the real-time PCR analysis
Gene (accession no.) Sense Primer (5’-3’) Antisense Primer (5’-3’) Amplicon length
GAD65 (NM_012563.1) CAGCCTGTGAAGGAGAAAGG GGTCTGCCAATTCCCAATTA 159 bp
GAD67 (M76177.1) CTGGAGCTGGCTGAATACCT TCGGAGGCTTTGTGGTATGT 146 bp
TPH2 (NM_173839.2) GGGTTACTTTCCTCCATCGGA AAGCAGGTTGTCTTCGGGTC 119 bp
GS (M29579.1) CCACTGTCCCTGGGCTTAGTTTA AGTGACATGCTAGTCCCACCAA 85 bp
TH (NM_012740.3) CTCCTCACCTATGCATTCAC TCCAATGTCCTGGGAGAACT 105 bp
β-Actin (NM031144) CATCCTGCGTCTGGACCTGG TAATGTCACGCACGATTTCC 116 bp
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SYBR® Premix Ex TaqTM (Takara RR820A, China) and
gene-specific primers. Relative quantitation for PCR prod-
uct was normalized to β-actin mRNA values obtained
from the same tissue. The sequences of gene- specific
primers are provided in Table 5.
Statistical analysis
Results from the experiment were expressed as means ±
SEM and analyzed using SPSS software. Differences be-
tween groups were determined by one-way analysis of
variance (ANOVA) for multiple comparisons followed by
TUKEY or Dunnett’s t test for post-hoc comparisons.
Pearson correlation analysis was used to evaluate possible
associations between certain FA and neurotransmitters. A
p < 0.05 was considered statistically significant.
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